Resveratrol: An overview of its anti-cancer mechanisms

M Elshaer, Y Chen, XJ Wang, X Tang - Life sciences, 2018 - Elsevier
Cancer is one of the leading causes of death worldwide. Chemotherapy and radiotherapy
are the conventional primary treatments for cancer patients. However, most of cancer cells …

Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators

IF Zattoni, LC Delabio, J de Paula Dutra, DH Kita… - European journal of …, 2022 - Elsevier
The primary source of failure of cancer therapies is multidrug resistance (MDR), which can
be caused by different mechanisms, including the overexpression of ABC transporters in …

Anticancer activity of stilbene‐based derivatives

B De Filippis, A Ammazzalorso, M Fantacuzzi… - …, 2017 - Wiley Online Library
Stilbene is an abundant structural scaffold in nature, and stilbene‐based compounds have
been widely reported for their biological activity. Notably,(E)‐resveratrol and its natural …

Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development

M Moinul, SA Amin, T Jha, S Gayen - European Journal of Medicinal …, 2022 - Elsevier
ATP-binding cassette (ABC) transporters are pivotal for cell detoxification and survival.
Overexpression of ABC transporter in tumor cells lead to chemoresistance through the efflux …

Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2

K Juvale, K Stefan, M Wiese - European journal of medicinal chemistry, 2013 - Elsevier
Multidrug resistance (MDR) often leads to a failure of cancer chemotherapy. Breast Cancer
Resistance Protein (BCRP/ABCG2), a member of the superfamily of ATP binding cassette …

ABCG2/BCRP: specific and nonspecific modulators

D Peña‐Solórzano, SA Stark, B König… - Medicinal research …, 2017 - Wiley Online Library
Multidrug resistance (MDR) in cancer cells is the development of resistance to a variety of
structurally and functionally nonrelated anticancer drugs. This phenomenon has become a …

Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity

G Valdameri, C Gauthier, R Terreux… - Journal of medicinal …, 2012 - ACS Publications
ABCG2 plays a major role in anticancer-drug efflux and related tumor multidrug resistance.
Potent and selective ABCG2 inhibitors with low cytotoxicity were investigated among a …

Natural-derived polyphenols as potential anticancer agents

C Spatafora, C Tringali - Anti-Cancer Agents in Medicinal …, 2012 - ingentaconnect.com
In this short review we report selected examples from recent literature to show the potential
of natural-derived, low molecular weight polyphenols as antitumor agents. The two major …

Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein

G Valdameri, E Genoux-Bastide, B Peres… - Journal of medicinal …, 2012 - ACS Publications
A series of 13 disubstituted chromones was synthesized. Two types of substituents, on each
side of the scaffold, contributed to both the potency of ABCG2 inhibition and the cytotoxicity …

The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents

S Yu, J Zheng, Y Zhang, D Meng, Y Wang, X Xu… - Bioorganic & Medicinal …, 2023 - Elsevier
Chemotherapy is the mainstay in the treatment of breast cancer. However, many drugs that
are commonly used in clinical practice have a high incidence of side effects and multidrug …